Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.

Cancian L, Bosshard R, Lucchesi W, Karstegl CE, Farrell PJ.

PLoS Pathog. 2011 Jul;7(7):e1002164. doi: 10.1371/journal.ppat.1002164. Epub 2011 Jul 28.

2.

A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.

Tzellos S, Correia PB, Karstegl CE, Cancian L, Cano-Flanagan J, McClellan MJ, West MJ, Farrell PJ.

J Virol. 2014 Aug;88(16):8743-53. doi: 10.1128/JVI.01000-14. Epub 2014 May 21.

3.

Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.

Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.

J Immunol Methods. 2012 Nov 30;385(1-2):60-70. doi: 10.1016/j.jim.2012.08.008. Epub 2012 Aug 18.

PMID:
22921685
5.

Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.

McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB.

Methods. 1997 Jan;11(1):83-7.

PMID:
8990093
6.
7.

[Studies on transforming functions of Epstein-Barr virus-specific proteins].

Kinoshita T.

Hokkaido Igaku Zasshi. 1990 Jul;65(4):362-75. Japanese.

PMID:
2172130
10.

Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Lucchesi W, Brady G, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ.

J Virol. 2008 Aug;82(15):7456-66. doi: 10.1128/JVI.00223-08. Epub 2008 May 14.

11.

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

Kis LL, Takahara M, Nagy N, Klein G, Klein E.

Immunol Lett. 2006 Apr 15;104(1-2):83-8. Epub 2005 Dec 1. Review.

PMID:
16386314
12.
13.

Immortalizing genes of Epstein-Barr virus.

Middleton T, Gahn TA, Martin JM, Sugden B.

Adv Virus Res. 1991;40:19-55. Review.

PMID:
1659776
14.

Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.

Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dölken G.

Blood. 1992 Jul 15;80(2):459-69.

16.

Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.

Spender LC, Cornish GH, Rowland B, Kempkes B, Farrell PJ.

J Virol. 2001 Apr;75(8):3537-46.

18.

c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.

Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J.

J Virol. 2009 May;83(10):5014-27. doi: 10.1128/JVI.02264-08. Epub 2009 Mar 4.

19.
20.

Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

Hertle ML, Popp C, Petermann S, Maier S, Kremmer E, Lang R, Mages J, Kempkes B.

PLoS Pathog. 2009 Jul;5(7):e1000506. doi: 10.1371/journal.ppat.1000506. Epub 2009 Jul 3.

Supplemental Content

Support Center